Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease SOUTH SAN Francisco,[…]
Read moreGlobal Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease SOUTH SAN Francisco,[…]
Read more